IT & Data Management
Mixed Reactions From Scientists As AI Emerges Pharma Sector
Artificial Intelligence remains a hot topic in the pharma spectrum, and the current ChatGPT wave has begun many more conversations. As of now, there happens to be a bifurcation of attitudes, with some researchers pretty much excited when it...
IT & Data Management
The Rising Value of Machine Learning In Pharmaceuticals
Machine learning, when it comes to the pharma sector, had a value of almost $1.2 billion in 2021, and it is anticipated to touch $26.2 billion in another 10 years, with a CAGR of 37.9% right from 2022 to...
News
Biotech Firms In Switzerland Prepare For European Launch
Analysis shows Switzerland has become the chosen headquarters for 20 per cent of European biotech companies. Out of a total of 265 companies that have settled in Switzerland, 63 of them are in the biotech sector, making it the...
IT & Data Management
Overcoming Counterfeit Challenges With Blockchain In Pharma
Researchers from Sweden have identified the advantages of employing smart contracts on blockchain platforms within the pharmaceutical supply chain to combat counterfeit drugs. Despite the estimated value of the counterfeit market exceeding $200 billion and the numerous benefits it...
News
Inizio Targets Innovation and AI-Led Growth with Two Top Appointments
Inizio, a partner for health and life sciences that seamlessly connects best-in-class strategic, analytic and creative capabilities has strengthened its senior leadership team at Inizio Medical with the dual appointments of Matt Lewis as Global Chief Artificial and Augmented Intelligence Officer and Paul...
Drug Research
Hydroxyprogesterone Caproate – Effectiveness Reviewed By EMA
The European Medicines Agency (EMA) has initiated a review of medications containing hydroxyprogesterone due to concerns regarding their safety and efficacy. These medications, known as hydroxyprogesterone caproate, are administered via injections to prevent pregnancy loss or premature birth in...
Drug Research
Indian Genomics Market Growth Will Lead To Affordability
The Indian genomics market is projected to grow by 18% in the next five years, driven by the decreasing costs of tests and increased affordability for the middle class and above. This growth aligns with the global genomics market,...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read